Reporting owner · CIK 0001737329

Iannone Robert

Visual SEC Form 4 history across 1 companies, 21 transactions and 4 filings.

EVP, GHR, D, CMOEVP, Global Head of R&D & CMOJazz Pharmaceuticals plc
Open-market mix
Latest filingAug 31, 2026, 10:45 PM
Filings4Form 4 records
Buying$00 purchases
Selling$20.2M8 sales
Net value−$20.2MBuys minus sells
Companies13 securities
Most recentAug 27, 2026exercise

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
1050-5-10Jan 25Feb 252Mar 256Aug 26

Net value flow

Buys minus sells

Jan 25
$0
Feb 25
$0
Mar 25
−$981.3K
Aug 26
−$19.2M

Transaction texture

Ownership and ticket size

Average P/S size$2.5M
Median P/S size$2.6M
Direct21
Indirect0
Aug 27, 2026exercise

Filing-only signals

Deterministic matches in this insider's history

Cluster Sellingpattern2Derivative Transactionfiling-context4Direct Ownershipfiling-context21Large Holdings Reductionholdings1Large Salesize5Repeat Sellerpattern610b5-1 Detectedfiling-context17

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at Jazz Pharmaceuticals plc on Aug 27, 2026 valued at $75,828.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at Jazz Pharmaceuticals plc on Aug 27, 2026 valued at $75,828.

Review SEC filing

Associated companies

Visual map of known reporting history

JAZZJazz Pharmaceuticals plc21 transactions · latest Aug 31, 2026, 10:45 PM
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
JAZZIannone Robert
EVPGHRD+1
exercise10b5-127.5k$0M
Derivative Transaction Direct Ownership 10b5-1 Detected
0.0%08/3108/27
JAZZIannone Robert
EVPGHRD+1
exercise10b5-126.1k$0M
Derivative Transaction Direct Ownership 10b5-1 Detected
0.0%08/3108/27
JAZZIannone Robert
EVPGHRD+1
exercise10b5-12.91k$0M
Derivative Transaction Direct Ownership 10b5-1 Detected
0.0%08/3108/27
JAZZIannone Robert
EVPGHRD+1
exercise10b5-1884$0M
Derivative Transaction Direct Ownership 10b5-1 Detected
0.0%08/3108/27
JAZZIannone Robert
EVPGHRD+1
sale10b5-1300-$7.58MS
Direct Ownership Repeat Seller 10b5-1 Detected
0.0%08/3108/27
JAZZIannone Robert
EVPGHRD+1
sale10b5-19.25k-$233MS
Direct Ownership Large Sale Repeat Seller+1
0.0%08/3108/27
JAZZIannone Robert
EVPGHRD+1
sale10b5-119.6k-$492MS
Direct Ownership Large Holdings Reduction Large Sale+2
0.0%08/3108/27
JAZZIannone Robert
EVPGHRD+1
sale10b5-118.1k-$452MS
Direct Ownership Large Sale Repeat Seller+1
0.0%08/3108/27
JAZZIannone Robert
EVPGHRD+1
sale10b5-111.4k-$284MS
Direct Ownership Large Sale Repeat Seller+1
0.0%08/3108/27
JAZZIannone Robert
EVPGHRD+1
sale10b5-118.1k-$450MS
Direct Ownership Large Sale 10b5-1 Detected
0.0%08/3108/27

Iannone Robert Insider Activity FAQ

SEC Form 4 context

Who is Iannone Robert?

Iannone Robert is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001737329.

Which companies has Iannone Robert reported transactions for?

Jazz Pharmaceuticals plc

When was Iannone Robert's latest insider buy?

No open-market insider purchase is available for this period.

When was Iannone Robert's latest insider sale?

sale at Jazz Pharmaceuticals plc on Aug 27, 2026 valued at $75,828.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.